Elzonris and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Elzonris (tagraxofusp-erzs), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Imitrex, and have Immune system disorder.

The phase IV clinical study analyzes which people have Rashes when taking Elzonris. It is created by eHealthMe based on reports of 405 people who have side effects when taking Elzonris from the FDA, and is updated regularly.

What is Elzonris?

Elzonris has active ingredients of tagraxofusp-erzs. eHealthMe is studying from 405 Elzonris users. Check the latest studies of Elzonris.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 16, 2026

405 people reported to have side effects when taking Elzonris.
Among them, 17 people (4.2%) have Rashes.

Among these 17 people:

How long have people been on Elzonris when they have Rashes? *

What is the gender of people who have Rashes when taking Elzonris? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Rashes when taking Elzonris? *

What are other drugs people take besides Elzonris? *

What are other side effects people have besides Rashes? *

Thrombocytopenia (decrease of platelets in blood): 6 people, 35.29%
Blood Albumin Decreased: 4 people, 23.53%
Transaminases Increased: 4 people, 23.53%
Blood Lactate Dehydrogenase Increased: 4 people, 23.53%
Weight Increased: 3 people, 17.65%
Capillary Leak Syndrome (capillary leaks plasma): 3 people, 17.65%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 11.76%
Hepatic Enzyme Increased: 2 people, 11.76%
Hepatotoxicity (chemical-driven liver damage): 2 people, 11.76%
Joint Swelling: 2 people, 11.76%

What are the existing conditions these people have? *

Oedema (fluid collection in tissue): 2 people, 11.76%
Migraine (headache): 2 people, 11.76%
Immune System Disorder: 2 people, 11.76%
Stress And Anxiety: 1 person, 5.88%
Stable Angina (a constant chest pain): 1 person, 5.88%
Peripheral Vascular Disorder: 1 person, 5.88%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Natural Killer-Cell Leukaemia (blood cancer of natural killer-cell): 1 person, 5.88%
Lymphoma (cancer that begins in immune system cells): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Elzonris and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elzonris:

Elzonris (405 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Elzonris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tagraxofusp-erzs (the active ingredients of Elzonris) and Elzonris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.